Analogs of ghrelin
US8258094B2 · kind B2 · utility
1Cited by
1References
80Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 28, 2008 |
| Grant date | Sep 4, 2012 |
| Priority date | — |
| Expiry date | Sep 20, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention comprises peptidyl analogs according to formulae (I) or (II) as depicted below:wherein the definitions of A1 to A28 and R1 to R3 are provided for in the specification for each of formulae (I) and (II), pharmaceutically acceptable salts thereof and pharmaceutical compositions comprising an effective amount of a compound of formula (I), that possess agonist or antagonist ghrelin activity, along with therapeutic and non-therapeutic uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.